About the Journal
Focus and Scope
The Canadian Journal of General Internal Medicine is an open access, peer reviewed journal which publishes 4 times yearly. The journal is circulated to all members of the Canadian Society of Internal Medicine as well as specialists with an interest in Internal Medicine. With a mix of clinical articles as well as academic articles, the CJGIM provides the highest level of content.The CJGIM accepts submissions under the categories of original research articles, review articles, case reports, letters to the editor, and book reviews. The CJGIM also publishes selected conference abstracts and special supplemental issues.
Peer Review Process
All submissions undergo an initial assessment to ensure adherence to journal requirements, including formatting of the manuscript and disclosure of any potential competing interests. Submissions may be returned to authors for queries at this stage.The Editor-in-Chief and Editorial Board will make an initial decision to send the manuscript for review or to reject without further review. Original research articles, review articles, case reports, and the contents of special supplemental issues undergo double blind peer review undertaken by a minimum of 2 reviewers whenever possible. Letters to the editor, book reviews, and conference abstracts undergo editorial review but are not peer reviewed. After the review is completed, one of the following decisions will be communicated to the authors: (1) Accept without revisions; (2) Accept with minor revisions; (3) Revise and resubmit; or (4) Reject. The journal aims to provide authors with a final decision within 8 weeks from the time of submission. Manuscripts must be submitted in English or French. At the discretion of the editors, manuscripts may be returned with a recommendation that the manuscript undergo language editing prior to resubmission.
The Editor-in-Chief and Editorial Board members are fully independent and are not compensated by the Canadian Society of Internal Medicine or Dougmar Publishing Group.
Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Please note that published articles are currently being archived with Portico.
Article Processing Charges
Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of articles published in all DPG titles is retained by the author. The author grants DPG the rights to publish the article and identify itself as the original publisher. The author grants DPG exclusive commercial rights to the article. The author grants any non-commercial third party the rights to use the article freely provided original author(s) and citation details are cited.
The Canadian Journal of General Internal Medicine began publication in 2006 under the guidance of the Editor-in-Chief Dr. Hector Baillie.
Under the leadership of former Editor-in-Chief Dr. Mitchell Levine, The Canadian Journal of General Internal Medicine is an electronic only, open access, peer-reviewed journal which publishes 4 issues yearly.
The Canadian Journal of General Internal Medicine is published four times a year by The Dougmar Publishing Group, with offices located at 115 King Street West, Suite 220, Dundas, ON L9H 1V1.
We welcome editorial submissions but cannot assume responsibility for unsolicited material. Any editorial material, including photographs that are accepted from an unsolicited contributor, will become the property of The Dougmar Publishing Group.
The publisher and the Canadian Society of Internal Medicine shall not be liable for any of the views expressed by the authors published in the Canadian Journal of General Internal Medicine, nor shall these opinions necessarily reflect those of the publisher.
Every effort has been made to ensure that the information provided here is accurate and in accordance with standards accepted at the time of printing.However, readers are advised to check the most current product information provided by the manufacturer of each drug to verify the recommended dose, the method and duration of administration, and contraindi-cations. It is the responsibility of the licensed prescriber to determine the dosages and best treatment for each patient. Neither the publisher the CSIM nor the editor assumes any liability for any injury and/or damage to persons or property arising from this publication.
For advertising inquiries please see our Media Kit
Or contact: email@example.com.